Ocean Biomedical, Inc. (OCEA) Earnings History
Net Loss6 years of earnings data (2019–2024) · Currently unprofitable on a TTM basis
Loading earnings history...
Ocean Biomedical, Inc. (OCEA) Earnings Overview
As of June 23, 2026, Ocean Biomedical, Inc. (OCEA) reported trailing twelve-month net income of -$31M, reflecting -153.2% year-over-year growth. The company earned $-1.12 per diluted share over the past four quarters.
Looking at the long-term picture, OCEA's historical earnings data spans multiple years. The company achieved its highest annual net income of $565,470 in fiscal 2022.
Ocean Biomedical, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including IMVT (-$506M net income), KALA (-$20M net income), AGEN ($65M net income, 0.1% margin), OCEA has comparable earnings metrics. Compare OCEA vs IMVT →
OCEA Earnings vs Peers
Earnings metrics vs comparable public companies
OCEA Historical Earnings Data (2019–2024)
5 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$3M | -683.8% | $0 | $-0.12 | - | - |
| 2022 | $565,470 | +100.9% | -$2M | $-0.05 | - | - |
| 2021 | -$62M | -3671.6% | $-566,558 | $-0.04 | - | - |
| 2020 | -$2M | -612.5% | -$2M | $-0.08 | - | - |
| 2019 | $-232,000 | - | $-232,000 | $-0.01 | - | - |
Download Data
Export OCEA earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
7+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
OCEA — Frequently Asked Questions
Quick answers to the most common questions about buying OCEA stock.
What is OCEA earnings per share (EPS)?
OCEA trailing twelve-month (TTM) diluted EPS is $-1.12, reflecting -153.2% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2019 to 2024 is available in the table on this page.
What is Ocean Biomedical, Inc.'s net income?
Ocean Biomedical, Inc. (OCEA) trailing twelve-month net income is $-31M as of 2024. Earnings declined -153.2% year-over-year.
Is OCEA profitable?
OCEA is not currently profitable on a TTM basis, reporting a net loss of $-31M. Net margin is N/A. Investors should monitor for a return to profitability.
What is OCEA's earnings growth rate?
OCEA compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2019 to 2024.
What are OCEA's profit margins?
Ocean Biomedical, Inc. net profit margin is N/A, operating margin is N/A, and gross margin is N/A. Below-average margins reflect competitive or cost pressures. Return on Equity is -98.8%.
Is OCEA growing earnings?
OCEA earnings are declining — EPS fell -153.2% year-over-year. TTM net income dropped to $-31M. This contrasts with the 5-year CAGR of N/A.
What was OCEA's best earnings year?
Ocean Biomedical, Inc.'s highest annual net income on record is $565470.00, achieved in fiscal year 2022. Earnings history on this page spans 2019 to 2024 and includes all annual and quarterly figures.
What were OCEA's earnings last quarter?
OCEA's most recent reported quarter was Q1 2025. Net income was $-8M with diluted EPS of $-0.30. For a full breakdown of all quarters, see the quarterly earnings table on this page.